thiorphan has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies
Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esser, N | 1 |
| Mundinger, TO | 1 |
| Barrow, BM | 1 |
| Zraika, S | 1 |
| Wang, Q | 1 |
| Zhao, Z | 1 |
| Shang, J | 1 |
| Xia, W | 1 |
2 other studies available for thiorphan and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Acute Inhibition of Intestinal Neprilysin Enhances Insulin Secretion via GLP-1 Receptor Signaling in Male Mice.
Topics: Animals; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Gluco | 2023 |
Targets and candidate agents for type 2 diabetes treatment with computational bioinformatics approach.
Topics: Benzophenanthridines; Computational Biology; Computer-Aided Design; Databases, Genetic; Diabetes Mel | 2014 |